Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes.

Mujoo K, Hunt CR, Pandita RK, Ferrari M, Krishnan S, Cooke JP, Hahn S, Pandita TK.

Mol Cancer Res. 2018 Aug;16(8):1209-1214. doi: 10.1158/1541-7786.MCR-17-0743. Epub 2018 Mar 28. Review.

PMID:
29592896
2.

Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination.

Mujoo K, Pandita RK, Tiwari A, Charaka V, Chakraborty S, Singh DK, Hambarde S, Hittelman WN, Horikoshi N, Hunt CR, Khanna KK, Kots AY, Butler EB, Murad F, Pandita TK.

Stem Cell Reports. 2017 Nov 14;9(5):1660-1674. doi: 10.1016/j.stemcr.2017.10.002. Epub 2017 Nov 2.

3.

Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells.

Dhupkar P, Zhao H, Mujoo K, An Z, Zhang N.

Biochem Biophys Rep. 2016 Oct 28;8:382-388. doi: 10.1016/j.bbrep.2016.10.009. eCollection 2016 Dec.

4.

Nuclear functions of β2-Spectrin in genomic stability.

Mujoo K, Hunt CR, Pandita TK.

Aging (Albany NY). 2016 Dec 14;8(12):3151-3152. doi: 10.18632/aging.101147. No abstract available.

5.

MCL-1 Depletion Impairs DNA Double-Strand Break Repair and Reinitiation of Stalled DNA Replication Forks.

Mattoo AR, Pandita RK, Chakraborty S, Charaka V, Mujoo K, Hunt CR, Pandita TK.

Mol Cell Biol. 2017 Jan 19;37(3). pii: e00535-16. doi: 10.1128/MCB.00535-16. Print 2017 Feb 1.

6.

Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer.

Zhang S, Mukherjee S, Fan X, Salameh A, Mujoo K, Huang Z, Li L, To'a Salazar G, Zhang N, An Z.

Oncotarget. 2016 Oct 4;7(40):65758-65769. doi: 10.18632/oncotarget.11613.

7.

Pluripotent Stem Cells and DNA Damage Response to Ionizing Radiations.

Mujoo K, Butler EB, Pandita RK, Hunt CR, Pandita TK.

Radiat Res. 2016 Jul;186(1):17-26. doi: 10.1667/RR14417.1. Epub 2016 Jun 22. Review.

8.

β2-spectrin depletion impairs DNA damage repair.

Horikoshi N, Pandita RK, Mujoo K, Hambarde S, Sharma D, Mattoo AR, Chakraborty S, Charaka V, Hunt CR, Pandita TK.

Oncotarget. 2016 Jun 7;7(23):33557-70. doi: 10.18632/oncotarget.9677.

9.

A multifaceted role for MOF histone modifying factor in genome maintenance.

Mujoo K, Hunt CR, Horikoshi N, Pandita TK.

Mech Ageing Dev. 2017 Jan;161(Pt A):177-180. doi: 10.1016/j.mad.2016.03.012. Epub 2016 Mar 30. Review.

10.

Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.

Torres MJ, Pandita RK, Kulak O, Kumar R, Formstecher E, Horikoshi N, Mujoo K, Hunt CR, Zhao Y, Lum L, Zaman A, Yeaman C, White MA, Pandita TK.

Mol Cell Biol. 2015 Nov;35(21):3633-45. doi: 10.1128/MCB.00768-15. Epub 2015 Aug 17.

11.

Regulation of ERBB3/HER3 signaling in cancer.

Mujoo K, Choi BK, Huang Z, Zhang N, An Z.

Oncotarget. 2014 Nov 15;5(21):10222-36. Review.

12.

The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.

Huang Z, Choi BK, Mujoo K, Fan X, Fa M, Mukherjee S, Owiti N, Zhang N, An Z.

Oncogene. 2015 Feb 26;34(9):1105-15. doi: 10.1038/onc.2014.56. Epub 2014 Mar 24.

PMID:
24662824
13.

Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway.

Mujoo K, Nikonoff LE, Sharin VG, Bryan NS, Kots AY, Murad F.

Protein Cell. 2012 Jul;3(7):535-44. doi: 10.1007/s13238-012-2053-2. Epub 2012 Jul 10.

14.

Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Mujoo K, Krumenacker JS, Murad F.

Free Radic Biol Med. 2011 Dec 15;51(12):2150-7. doi: 10.1016/j.freeradbiomed.2011.09.037. Epub 2011 Oct 6. Review.

15.

Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.

Sharin VG, Mujoo K, Kots AY, Martin E, Murad F, Sharina IG.

Stem Cells Dev. 2011 Jul;20(7):1287-93. doi: 10.1089/scd.2010.0411. Epub 2010 Dec 6.

16.

Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.

Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F.

Nitric Oxide. 2010 Jan 1;22(1):43-50. doi: 10.1016/j.niox.2009.11.007. Epub 2009 Dec 3.

17.

Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells.

Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, Parveen S, Nikonoff LE, Kots AY, Murad F.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18924-9. doi: 10.1073/pnas.0810230105. Epub 2008 Nov 19.

18.
19.

Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.

Mujoo K, Watanabe M, Khokhar AR, Siddik ZH.

Prostate. 2005 Jan 1;62(1):91-100.

PMID:
15389812
20.

Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.

Mujoo K, Watanabe M, Nakamura J, Khokhar AR, Siddik ZH.

J Cancer Res Clin Oncol. 2003 Dec;129(12):709-18. Epub 2003 Sep 26.

PMID:
14513366
21.

Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis.

Mujoo K, Haridas V, Hoffmann JJ, Wächter GA, Hutter LK, Lu Y, Blake ME, Jayatilake GS, Bailey D, Mills GB, Gutterman JU.

Cancer Res. 2001 Jul 15;61(14):5486-90.

22.

Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation.

Haridas V, Higuchi M, Jayatilake GS, Bailey D, Mujoo K, Blake ME, Arntzen CJ, Gutterman JU.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5821-6.

24.

Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma.

Murray JL, Kleinerman ES, Jia SF, Rosenblum MG, Eton O, Buzaid A, Legha S, Ross MI, Thompson L, Mujoo K, Rieger PT, Saleh M, Khazaeli MB, Vadhan-Raj S.

J Immunother Emphasis Tumor Immunol. 1996 May;19(3):206-17.

PMID:
8811495
25.

Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma.

Mujoo K, Maneval DC, Anderson SC, Gutterman JU.

Oncogene. 1996 Apr 18;12(8):1617-23.

PMID:
8622881
26.

Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells.

Rosenblum MG, Cheung L, Kim SK, Mujoo K, Donato NJ, Murray JL.

Cancer Immunol Immunother. 1996 Feb;42(2):115-21.

PMID:
8620520
27.

Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.

Mujoo K, Cheung L, Murray JL, Rosenblum MG.

Cancer Immunol Immunother. 1995 May;40(5):339-45.

PMID:
7600567
28.
29.

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.

Murray JL, Cunningham JE, Brewer H, Mujoo K, Zukiwski AA, Podoloff DA, Kasi LP, Bhadkamkar V, Fritsche HA, Benjamin RS, et al.

J Clin Oncol. 1994 Jan;12(1):184-93.

PMID:
8270976
30.

Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells.

Mujoo K, Donato NJ, Lapushin R, Rosenblum MG, Murray JL.

J Immunother Emphasis Tumor Immunol. 1993 Apr;13(3):166-74.

PMID:
8471591
31.
32.

Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate.

Murray JL, Mujoo K, Wilmanns C, Mansfield P, Wilbur DS, Rosenblum MG.

J Nucl Med. 1991 Feb;32(2):279-87.

33.

A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.

Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG.

Cancer Immunol Immunother. 1991;34(3):198-204.

PMID:
1756537
34.

Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.

Murray JL, Zukiwski AA, Mujoo K, Rosenblum MG.

J Biol Response Mod. 1990 Dec;9(6):556-63.

PMID:
2074442
35.

Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.

Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA.

Cancer Res. 1989 Jun 1;49(11):2857-61.

36.

A human brain glycoprotein related to the mouse cell adhesion molecule L1.

Wolff JM, Frank R, Mujoo K, Spiro RC, Reisfeld RA, Rathjen FG.

J Biol Chem. 1988 Aug 25;263(24):11943-7.

37.
38.
39.

Characterization of a unique glycoprotein antigen expressed on the surface of human neuroblastoma cells.

Mujoo K, Spiro RC, Reisfeld RA.

J Biol Chem. 1986 Aug 5;261(22):10299-305.

40.
41.

Isolation, characterization, and synthesis of alpha-fetoprotein from neonatal rat brain.

Mujoo K, Ali M, Sahib MK.

J Neurochem. 1983 Nov;41(5):1223-8.

PMID:
6194262
42.
44.

Supplemental Content

Support Center